Abstract
Common genetic variants identified in the general population have been found to increase phenotypic risks among individuals with certain genetic conditions. Up to 90% of individuals with tuberous sclerosis complex (TSC) are affected by some type of epilepsy, yet the common variants contributing to epilepsy risk in the general population have not been evaluated in the context of TSC-associated epilepsy. Such knowledge is important to help uncover the underlying pathogenesis of epilepsy in TSC which is not fully understood, and critical as uncontrolled epilepsy is a major problem in this population. To evaluate common genetic modifiers of epilepsy, our study pooled phenotypic and genotypic data from 369 individuals with TSC to evaluate known and novel epilepsy common variants. We did not find evidence of enhanced genetic penetrance for known epilepsy variants identified across the largest genome-wide association studies of epilepsy in the general population, but identified support for novel common epilepsy variants in the context of TSC. Specifically, we have identified a novel signal in SLC7A1 that may be functionally involved in pathways relevant to TSC and epilepsy. Our study highlights the need for further evaluation of genetic modifiers in TSC to aid in further understanding of epilepsy in TSC and improve outcomes.
Original language | English (US) |
---|---|
Article number | e63569 |
Journal | American Journal of Medical Genetics, Part A |
Volume | 194 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2024 |
Funding
This work was supported by the Early Biomarkers of Autism Spectrum Disorders in infants with Tuberous Sclerosis (1U01NS082320‐01), the Developmental Synaptopathies Consortium (1U54NS092090‐01), and the Department of Defense (W81XWH1810537). The Developmental Synaptopathies Consortium is part of the Rare Diseases Clinical Research Network (RDCRN), an initiative of the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS). Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NINDS), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institute of Mental Health (NIMH), and National Center for Advancing Translational Sciences (NCATS).
Keywords
- common variants
- epilepsy
- genetic modifiers
- tuberous sclerosis complex
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)